Yesterday, the U.S. Food and Drug Administration approved the first in a new class of drugs designed to prevent migraines. This feature, originally published on 8 January 2016, describes the history of these drugs, the powerful relief they can bring some patients, and the limitations that still exist with them.

You must be logged in to post a comment.